{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:38:02Z","timestamp":1790267882935,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vascular dysfunction is an important phenomenon in hypertension. We hypothesized that angiotensin II (AngII) affects transcriptome in the vasculature in a region-specific manner, which may help to identify genes related to vascular dysfunction in AngII-induced hypertension. Mesenteric artery and aortic transcriptome was profiled using Illumina WG-6v2.0 chip in control and AngII infused (490\u2009ng\/kg\/min) hypertensive mice. Gene set enrichment and leading edge analyses identified <jats:italic>Sphingosine kinase 1 (Sphk1)<\/jats:italic> in the highest number of pathways affected by AngII. Sphk1 mRNA, protein and activity were up-regulated in the hypertensive vasculature. Chronic sphingosine-1-phosphate (S1P) infusion resulted in a development of significantly increased vasoconstriction and endothelial dysfunction. AngII-induced hypertension was blunted in <jats:italic>Sphk1<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice (systolic BP 167\u2009\u00b1\u20094.2 vs. 180\u2009\u00b1\u20093.3\u2009mmHg, p\u2009&lt;\u20090.05), which was associated with decreased aortic and mesenteric vasoconstriction in hypertensive <jats:italic>Sphk1<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice. Pharmacological inhibition of S1P synthesis reduced vasoconstriction of mesenteric arteries. While Sphk1 is important in mediating vasoconstriction in hypertension, <jats:italic>Sphk1<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice were characterized by enhanced endothelial dysfunction, suggesting a local protective role of Sphk1 in the endothelium. S1P serum level in humans was correlated with endothelial function (arterial tonometry). Thus, vascular transcriptome analysis shows that S1P pathway is critical in the regulation of vascular function in AngII-induced hypertension, although <jats:italic>Sphk1<\/jats:italic> may have opposing roles in the regulation of vasoconstriction and endothelium-dependent vasorelaxation.<\/jats:p>","DOI":"10.1038\/srep44131","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T10:08:22Z","timestamp":1489054102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Vascular transcriptome profiling identifies Sphingosine kinase 1 as a modulator of angiotensin II-induced vascular dysfunction"],"prefix":"10.1038","volume":"7","author":[{"given":"Mateusz","family":"Siedlinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Nosalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Szczepaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka H.","family":"Ludwig-Ga\u0142\u0119zowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Miko\u0142ajczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Filip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Osmenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Wilk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Wo\u0142kow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz J.","family":"Guzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"key":"BFsrep44131_CR1","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/nm.2541","volume":"17","author":"TM Coffman","year":"2011","unstructured":"Coffman, T. M. Under pressure: The search for the essential mechanisms of hypertension. Nat Med 17, 1402\u20131409 (2011).","journal-title":"Nat Med"},{"key":"BFsrep44131_CR2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ng.384","volume":"41","author":"D Levy","year":"2009","unstructured":"Levy, D. et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 41, 677\u2013687 (2009).","journal-title":"Nat Genet"},{"key":"BFsrep44131_CR3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","volume":"478","author":"GB Ehret","year":"2011","unstructured":"Ehret, G. B. et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478, 103\u2013109 (2011).","journal-title":"Nature"},{"key":"BFsrep44131_CR4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.834","volume":"43","author":"N Kato","year":"2011","unstructured":"Kato, N. et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east asians. Nat Genet 43, 531\u2013538 (2011).","journal-title":"Nat Genet"},{"key":"BFsrep44131_CR5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ng.922","volume":"43","author":"LV Wain","year":"2011","unstructured":"Wain, L. V. et al. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet 43, 1005\u20131011 (2011).","journal-title":"Nat Genet"},{"key":"BFsrep44131_CR6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ng.120","volume":"40","author":"E Zeggini","year":"2008","unstructured":"Zeggini, E. et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40, 638\u2013645 (2008).","journal-title":"Nat Genet"},{"key":"BFsrep44131_CR7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/hmg\/ddr524","volume":"21","author":"MH Cho","year":"2012","unstructured":"Cho, M. H. et al. A genome-wide association study of copd identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet 21, 947\u2013957 (2012).","journal-title":"Hum Mol Genet"},{"key":"BFsrep44131_CR8","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","volume":"204","author":"TJ Guzik","year":"2007","unstructured":"Guzik, T. J. et al. Role of the t cell in the genesis of angiotensin ii induced hypertension and vascular dysfunction. J Exp Med 204, 2449\u20132460 (2007).","journal-title":"J Exp Med"},{"key":"BFsrep44131_CR9","first-page":"E85","volume":"86","author":"TJ Guzik","year":"2000","unstructured":"Guzik, T. J. et al. Vascular superoxide production by nad(p)h oxidase: Association with endothelial dysfunction and clinical risk factors. Circ Res 86, E85\u201390 (2000).","journal-title":"Circ Res"},{"key":"BFsrep44131_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1152\/physiolgenomics.00063.2010","volume":"42A","author":"NA Makhanova","year":"2010","unstructured":"Makhanova, N. A., Crowley, S. D., Griffiths, R. C. & Coffman, T. M. Gene expression profiles linked to at1 angiotensin receptors in the kidney. Physiol Genomics 42A, 211\u2013218 (2010).","journal-title":"Physiol Genomics"},{"key":"BFsrep44131_CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nmeth757","volume":"2","author":"JE Larkin","year":"2005","unstructured":"Larkin, J. E., Frank, B. C., Gavras, H., Sultana, R. & Quackenbush, J. Independence and reproducibility across microarray platforms. Nat Methods 2, 337\u2013344 (2005).","journal-title":"Nat Methods"},{"key":"BFsrep44131_CR12","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1096\/fj.10-174615","volume":"25","author":"K Tsushima","year":"2011","unstructured":"Tsushima, K. et al. Irf3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin ii-induced hypertension. FASEB J 25, 1531\u20131543 (2011).","journal-title":"FASEB J"},{"key":"BFsrep44131_CR13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1471-2164-10-298","volume":"10","author":"C Rush","year":"2009","unstructured":"Rush, C. et al. Whole genome expression analysis within the angiotensin ii-apolipoprotein e deficient mouse model of abdominal aortic aneurysm. BMC Genomics 10, 298 (2009).","journal-title":"BMC Genomics"},{"key":"BFsrep44131_CR14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCRESAHA.109.212837","volume":"106","author":"AP Owens 3rd","year":"2010","unstructured":"Owens, A. P. 3rd et al. Angiotensin ii induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3. Circ Res 106, 611\u2013619 (2010).","journal-title":"Circ Res"},{"key":"BFsrep44131_CR15","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.RES.0000101912.01071.FF","volume":"93","author":"Y Zhou","year":"2003","unstructured":"Zhou, Y., Chen, Y., Dirksen, W. P., Morris, M. & Periasamy, M. At1b receptor predominantly mediates contractions in major mouse blood vessels. Circ Res 93, 1089\u20131094 (2003).","journal-title":"Circ Res"},{"key":"BFsrep44131_CR16","doi-asserted-by":"crossref","first-page":"e48462","DOI":"10.1371\/journal.pone.0048462","volume":"7","author":"A Poduri","year":"2012","unstructured":"Poduri, A. et al. Regional variation in aortic at1b receptor mrna abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms. PLoS One 7, e48462 (2012).","journal-title":"PLoS One"},{"key":"BFsrep44131_CR17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.36.3.312","volume":"36","author":"HD Intengan","year":"2000","unstructured":"Intengan, H. D. & Schiffrin, E. L. Structure and mechanical properties of resistance arteries in hypertension: Role of adhesion molecules and extracellular matrix determinants. Hypertension 36, 312\u2013318 (2000).","journal-title":"Hypertension"},{"key":"BFsrep44131_CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.mn.7800143","volume":"9","author":"RL Prewitt","year":"2002","unstructured":"Prewitt, R. L., Rice, D. C. & Dobrian, A. D. Adaptation of resistance arteries to increases in pressure. Microcirculation 9, 295\u2013304 (2002).","journal-title":"Microcirculation"},{"key":"BFsrep44131_CR19","doi-asserted-by":"crossref","first-page":"G1203","DOI":"10.1152\/ajpgi.00578.2005","volume":"290","author":"T Petnehazy","year":"2006","unstructured":"Petnehazy, T. et al. Angiotensin ii type 1 receptors and the intestinal microvascular dysfunction induced by ischemia and reperfusion. Am J Physiol Gastrointest Liver Physiol 290, G1203\u20131210 (2006).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFsrep44131_CR20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000089969","volume":"43","author":"D Wang","year":"2006","unstructured":"Wang, D., Chabrashvili, T., Borrego, L., Aslam, S. & Umans, J. G. Angiotensin ii infusion alters vascular function in mouse resistance vessels: Roles of o and endothelium. J Vasc Res 43, 109\u2013119 (2006).","journal-title":"J Vasc Res"},{"key":"BFsrep44131_CR21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.coph.2006.09.008","volume":"7","author":"SL Peters","year":"2007","unstructured":"Peters, S. L. & Alewijnse, A. E. Sphingosine-1-phosphate signaling in the cardiovascular system. Current opinion in pharmacology 7, 186\u2013192 (2007).","journal-title":"Current opinion in pharmacology"},{"key":"BFsrep44131_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCGENETICS.113.000343","volume":"7","author":"JV Moxon","year":"2014","unstructured":"Moxon, J. V. et al. Comparison of the serum lipidome in patients with abdominal aortic aneurysm and peripheral artery disease. Circulation. Cardiovascular genetics 7, 71\u201379 (2014).","journal-title":"Circulation. Cardiovascular genetics"},{"key":"BFsrep44131_CR23","first-page":"11930","volume":"8","author":"XQ Xing","year":"2015","unstructured":"Xing, X. Q. et al. Sphingosine kinase 1\/sphingosine 1-phosphate signalling pathway as a potential therapeutic target of pulmonary hypertension. International journal of clinical and experimental medicine 8, 11930\u201311935 (2015).","journal-title":"International journal of clinical and experimental medicine"},{"key":"BFsrep44131_CR24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.lfs.2013.07.017","volume":"93","author":"IA Gorshkova","year":"2013","unstructured":"Gorshkova, I. A. et al. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest. Life sciences 93, 359\u2013366 (2013).","journal-title":"Life sciences"},{"key":"BFsrep44131_CR25","doi-asserted-by":"crossref","first-page":"52487","DOI":"10.1074\/jbc.M406512200","volume":"279","author":"ML Allende","year":"2004","unstructured":"Allende, M. L. et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by fty720. The Journal of biological chemistry 279, 52487\u201352492 (2004).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep44131_CR26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/me.2014-1388","volume":"29","author":"PC Wilson","year":"2015","unstructured":"Wilson, P. C. et al. Inhibition of sphingosine kinase 1 ameliorates angiotensin ii-induced hypertension and inhibits transmembrane calcium entry via store-operated calcium channel. Molecular endocrinology 29, 896\u2013908 (2015).","journal-title":"Molecular endocrinology"},{"key":"BFsrep44131_CR27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1096\/fj.12-219014","volume":"27","author":"H Furuya","year":"2013","unstructured":"Furuya, H. et al. Effect of sphingosine kinase 1 inhibition on blood pressure. FASEB J 27, 656\u2013664 (2013).","journal-title":"FASEB J"},{"key":"BFsrep44131_CR28","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0006-2952(03)00546-X","volume":"66","author":"F Coussin","year":"2003","unstructured":"Coussin, F., Scott, R. H. & Nixon, G. F. Sphingosine 1-phosphate induces creb activation in rat cerebral artery via a protein kinase c-mediated inhibition of voltage-gated k+ channels. Biochemical pharmacology 66, 1861\u20131870 (2003).","journal-title":"Biochemical pharmacology"},{"key":"BFsrep44131_CR29","first-page":"9","volume":"2","author":"S Salomone","year":"2011","unstructured":"Salomone, S. & Waeber, C. Selectivity and specificity of sphingosine-1-phosphate receptor ligands: Caveats and critical thinking in characterizing receptor-mediated effects. Frontiers in pharmacology 2, 9 (2011).","journal-title":"Frontiers in pharmacology"},{"key":"BFsrep44131_CR30","first-page":"26","volume":"2","author":"NJ Pyne","year":"2011","unstructured":"Pyne, N. J. & Pyne, S. Selectivity and specificity of sphingosine 1-phosphate receptor ligands: \u201cOff-targets\u201d or complex pharmacology? Frontiers in pharmacology 2, 26 (2011).","journal-title":"Frontiers in pharmacology"},{"key":"BFsrep44131_CR31","doi-asserted-by":"crossref","first-page":"R440","DOI":"10.1152\/ajpregu.00085.2006","volume":"292","author":"JN Lorenz","year":"2007","unstructured":"Lorenz, J. N., Arend, L. J., Robitz, R., Paul, R. J. & MacLennan, A. J. Vascular dysfunction in s1p2 sphingosine 1-phosphate receptor knockout mice. American journal of physiology . Regulatory, integrative and comparative physiology 292, R440\u2013446 (2007).","journal-title":"Regulatory, integrative and comparative physiology"},{"key":"BFsrep44131_CR32","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1111\/bph.12620","volume":"171","author":"DA Sykes","year":"2014","unstructured":"Sykes, D. A. et al. Investigating the molecular mechanisms through which fty720-p causes persistent s1p1 receptor internalization. British journal of pharmacology 171, 4797\u20134807 (2014).","journal-title":"British journal of pharmacology"},{"key":"BFsrep44131_CR33","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.3934","volume":"21","author":"A Cantalupo","year":"2015","unstructured":"Cantalupo, A. et al. Nogo-b regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure. Nat Med 21, 1028\u20131037 (2015).","journal-title":"Nat Med"},{"key":"BFsrep44131_CR34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.RES.0000164321.91452.00","volume":"96","author":"M Tolle","year":"2005","unstructured":"Tolle, M. et al. Immunomodulator fty720 induces enos-dependent arterial vasodilatation via the lysophospholipid receptor s1p3. Circ Res 96, 913\u2013920 (2005).","journal-title":"Circ Res"},{"key":"BFsrep44131_CR35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/hq0102.101843","volume":"22","author":"Y Rikitake","year":"2002","unstructured":"Rikitake, Y. et al. Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. Arteriosclerosis, thrombosis, and vascular biology 22, 108\u2013114 (2002).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"BFsrep44131_CR36","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1161\/01.ATV.0000237569.95046.b9","volume":"26","author":"AC Mulders","year":"2006","unstructured":"Mulders, A. C. et al. Sphingosine kinase-dependent activation of endothelial nitric oxide synthase by angiotensin ii. Arteriosclerosis, thrombosis, and vascular biology 26, 2043\u20132048 (2006).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"BFsrep44131_CR37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/cvr\/cvp064","volume":"82","author":"J Igarashi","year":"2009","unstructured":"Igarashi, J. & Michel, T. Sphingosine-1-phosphate and modulation of vascular tone. Cardiovasc Res 82, 212\u2013220 (2009).","journal-title":"Cardiovasc Res"},{"key":"BFsrep44131_CR38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bbrc.2016.06.009","volume":"476","author":"M Tolle","year":"2016","unstructured":"Tolle, M. et al. Regulation of endothelial nitric oxide synthase activation in endothelial cells by s1p1 and s1p3. Biochemical and biophysical research communications 476, 627\u2013634 (2016).","journal-title":"Biochemical and biophysical research communications"},{"key":"BFsrep44131_CR39","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ahj.2014.06.028","volume":"168","author":"J Camm","year":"2014","unstructured":"Camm, J., Hla, T., Bakshi, R. & Brinkmann, V. Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications. American heart journal 168, 632\u2013644 (2014).","journal-title":"American heart journal"},{"key":"BFsrep44131_CR40","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.110.226464","volume":"107","author":"J Hoefer","year":"2010","unstructured":"Hoefer, J. et al. Sphingosine-1-phosphate-dependent activation of p38 mapk maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction. Circ Res 107, 923\u2013933 (2010).","journal-title":"Circ Res"},{"key":"BFsrep44131_CR41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tem.2014.06.012","volume":"25","author":"GR Drummond","year":"2014","unstructured":"Drummond, G. R. & Sobey, C. G. Endothelial nadph oxidases: Which nox to target in vascular disease? Trends in endocrinology and metabolism: TEM 25, 452\u2013463 (2014).","journal-title":"Trends in endocrinology and metabolism: TEM"},{"key":"BFsrep44131_CR42","doi-asserted-by":"crossref","first-page":"e000731","DOI":"10.1161\/JAHA.113.000731","volume":"3","author":"KK Galougahi","year":"2014","unstructured":"Galougahi, K. K. et al. Glutathionylation mediates angiotensin ii-induced enos uncoupling, amplifying nadph oxidase-dependent endothelial dysfunction. Journal of the American Heart Association 3, e000731 (2014).","journal-title":"Journal of the American Heart Association"},{"key":"BFsrep44131_CR43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1189\/jlb.0510304","volume":"89","author":"V Schenten","year":"2011","unstructured":"Schenten, V., Melchior, C., Steinckwich, N., Tschirhart, E. J. & Brechard, S. Sphingosine kinases regulate nox2 activity via p38 mapk-dependent translocation of s100a8\/a9. Journal of leukocyte biology 89, 587\u2013596 (2011).","journal-title":"Journal of leukocyte biology"},{"key":"BFsrep44131_CR44","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1172\/JCI43464","volume":"120","author":"MS Denzel","year":"2010","unstructured":"Denzel, M. S. et al. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. The Journal of clinical investigation 120, 4342\u20134352 (2010).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep44131_CR45","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.2337\/db10-1321","volume":"60","author":"CM Chung","year":"2011","unstructured":"Chung, C. M. et al. A genome-wide association study reveals a quantitative trait locus of adiponectin on cdh13 that predicts cardiometabolic outcomes. Diabetes 60, 2417\u20132423 (2011).","journal-title":"Diabetes"},{"key":"BFsrep44131_CR46","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/hmg\/ddp135","volume":"18","author":"E Org","year":"2009","unstructured":"Org, E. et al. Genome-wide scan identifies cdh13 as a novel susceptibility locus contributing to blood pressure determination in two european populations. Hum Mol Genet 18, 2288\u20132296 (2009).","journal-title":"Hum Mol Genet"},{"key":"BFsrep44131_CR47","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/HYPERTENSIONAHA.110.159301","volume":"56","author":"M Carlstrom","year":"2010","unstructured":"Carlstrom, M. et al. Superoxide dismutase 1 limits renal microvascular remodeling and attenuates arteriole and blood pressure responses to angiotensin ii via modulation of nitric oxide bioavailability. Hypertension 56, 907\u2013913 (2010).","journal-title":"Hypertension"},{"key":"BFsrep44131_CR48","first-page":"313","volume":"56","author":"TJ Guzik","year":"2005","unstructured":"Guzik, T. J. et al. Superoxide dismutase activity and expression in human venous and arterial bypass graft vessels. Journal of physiology and pharmacology: an official journal of the Polish Physiological Society 56, 313\u2013323 (2005).","journal-title":"Journal of physiology and pharmacology: an official journal of the Polish Physiological Society"},{"key":"BFsrep44131_CR49","doi-asserted-by":"crossref","first-page":"H597","DOI":"10.1152\/ajpheart.00138.2012","volume":"303","author":"PA Crassous","year":"2012","unstructured":"Crassous, P. A. et al. Soluble guanylyl cyclase is a target of angiotensin ii-induced nitrosative stress in a hypertensive rat model. Am J Physiol Heart Circ Physiol 303, H597\u2013604 (2012).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep44131_CR50","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1021\/bi201060c","volume":"50","author":"S Ramanathan","year":"2011","unstructured":"Ramanathan, S., Mazzalupo, S., Boitano, S. & Montfort, W. R. Thrombospondin-1 and angiotensin ii inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration. Biochemistry 50, 7787\u20137799 (2011).","journal-title":"Biochemistry"},{"key":"BFsrep44131_CR51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ajhg.2011.02.005","volume":"88","author":"M Stuiver","year":"2011","unstructured":"Stuiver, M. et al. Cnnm2, encoding a basolateral protein required for renal mg2+ handling, is mutated in dominant hypomagnesemia. Am J Hum Genet 88, 333\u2013343 (2011).","journal-title":"Am J Hum Genet"},{"key":"BFsrep44131_CR52","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1194\/jlr.P054163","volume":"55","author":"H Obinata","year":"2014","unstructured":"Obinata, H. et al. Individual variation of human s1p(1) coding sequence leads to heterogeneity in receptor function and drug interactions. Journal of lipid research 55, 2665\u20132675 (2014).","journal-title":"Journal of lipid research"},{"key":"BFsrep44131_CR53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2369-15-58","volume":"15","author":"SP Hartono","year":"2014","unstructured":"Hartono, S. P., Knudsen, B. E., Lerman, L. O., Textor, S. C. & Grande, J. P. Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db\/db mice. BMC nephrology 15, 58 (2014).","journal-title":"BMC nephrology"},{"key":"BFsrep44131_CR54","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","volume":"64","author":"CL Andersen","year":"2004","unstructured":"Andersen, C. L., Jensen, J. L. & Orntoft, T. F. Normalization of real-time quantitative reverse transcription-pcr data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer research 64, 5245\u20135250 (2004).","journal-title":"Cancer research"},{"key":"BFsrep44131_CR55","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/1087057112468765","volume":"18","author":"RR Nazarewicz","year":"2013","unstructured":"Nazarewicz, R. R., Bikineyeva, A. & Dikalov, S. I. Rapid and specific measurements of superoxide using fluorescence spectroscopy. Journal of biomolecular screening 18, 498\u2013503 (2013).","journal-title":"Journal of biomolecular screening"},{"key":"BFsrep44131_CR56","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. Nih image to imagej: 25 years of image analysis. Nat Methods 9, 671\u2013675 (2012).","journal-title":"Nat Methods"},{"key":"BFsrep44131_CR57","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http:\/\/www.R-project.org\/ (2013)."},{"key":"BFsrep44131_CR58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. Pgc-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34, 267\u2013273 (2003).","journal-title":"Nat Genet"},{"key":"BFsrep44131_CR59","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102, 15545\u201315550 (2005).","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep44131","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep44131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep44131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T19:00:04Z","timestamp":1671822004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep44131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,9]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,4,11]]}},"alternative-id":["BFsrep44131"],"URL":"https:\/\/doi.org\/10.1038\/srep44131","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,9]]},"assertion":[{"value":"10 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44131"}}